Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 133 (abbreviated RN7SKP133) is a predicted non-coding pseudogene in Homo sapiens, related in sequence to the functional 7SK small nuclear RNA (RN7SK). The canonical gene, RN7SK, encodes a highly conserved small nuclear RNA (snRNA) that acts as a non-coding RNA regulating transcription elongation by associating with the 7SK ribonucleoprotein complex and modulating the activity of P-TEFb, a key player in RNA polymerase II–mediated transcription[1][2][7][5]. However, as a pseudogene, RN7SKP133 is typically annotated as non-functional and is not known to encode a biologically active RNA or protein. There is little evidence for specific biological function, disease association, or drug interaction for this pseudogene[6]. Its presence in genomic datasets reflects sequence similarity to RN7SK, but not an active molecular or therapeutic role.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 133 (RN7SKP133).